Daniel, C;Renders, L;Amann, K;Schulze-Lohoff, E;Hauser, IA;Hugo, CMechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat.Am J Transplant20055122849-61
Lutz, J;Yao, Y;Song, E;Antus, B;Hamar, P;Liu, S;Heemann, UInhibition of matrix metalloproteinases during chronic allograft nephropathy in rats.Transplantation2005796655-61
Vítko, S;Klinger, M;Salmela, K;Wlodarczyk, Z;Tyden, G;Senatorski, G;Ostrowski, M;Fauchald, P;Kokot, F;Stefoni, S;Perner, F;Claesson, K;Castagneto, M;Heemann, U;Carmellini, M;Squifflet, JP;Weber, M;Segoloni, G;Bäckman, L;Sperschneider, H;Krämer, BKTwo corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study.Transplantation200580121734-41
Hamar, P;Liptak, P;Heemann, U;Iványi, BUltrastructural analysis of the Fisher to Lewis rat model of chronic allograft nephropathy.Transpl Int2005187863-70
Margreiter, R;Pohanka, E;Sparacino, V;Sperschneider, H;Kunzendorf, U;Huber, W;Lameire, N;Andreucci, VE;Donati, D;Heemann, UOpen prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects.Transpl Int2005187816-23
Antus, B;Liu, S;Yao, Y;Zou, H;Song, E;Lutz, J;Heemann, UEffects of progesterone and selective oestrogen receptor modulators on chronic allograft nephropathy in rats.Nephrol Dial Transplant2005202329-35
Baum, H;von Meyer, A;Heemann, U;Hallbach, JBNP and NT-proBNP in patients with renal failure and haemodialysisClin Chim Acta2005355 Suppl.S112-S113
Zohlnhofer, D;Hausleiter, J;Kastrati, A;Mehilli, J;Goos, C;Schuhlen, H;Pache, J;Pogatsa-Murray, G;Heemann, U;Dirschinger, J;Schömig, AA randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.J Am Coll Cardiol200546111999-2003